Luteinizing hormone-releasing hormone (LHRH) analogue trials for Prostate cancer

All Luteinizing hormone-releasing hormone (LHRH) analogue trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Luteinizing hormone-releasing hormone (LHRH) analogue for Prostate cancer

• Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
  NCT06059118 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
  NCT07142551 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• The COSMYC Trial (COmbined Suppression of MYC)
  NCT06922318 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials study Luteinizing hormone-releasing hormone (LHRH) analogue for Prostate cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.